Endocrinologia

Estratégia Alimentar Nacional do Reino Unido | Relatório recomenda taxar sal e açúcar e prescrever vegetais.

21 Jul, 2021 | 09:47h

National Food Strategy: Tax sugar and salt and prescribe veg, report says – BBC

Relatório: National Food Strategy Independent Review

Relacionado: Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization (gratuito) E The Lancet taskforce on NCDs and economics (séries e comentários gratuitos) To improve global health, tax the things that are killing us – Financial Times (políticas, artigos e comentários gratuitos) E Reducing cardiovascular disease burden through targeted dietary policies (estudos e comentários gratuitos) E Fiscal policies for the prevention of diseases (estudo e comentário gratuito) E The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities (gratuito)

Estudo randomizado | Dose semanal de semaglutida 2 mg vs. 1 mg em pacientes com diabetes tipo 2 – A mudança média na HbA1c basal foi de -2,2 pontos percentuais com 2 mg vs. 1,9 pontos percentuais com 1 mg; a mudança média no peso corporal basal foi de -6,9 kg com 2 mg vs. -6 kg com 1 mg.

20 Jul, 2021 | 10:49h

Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial – The Lancet Endocrinology & Diabetes (link para o resumo – $ para o texto completo)

M-A | Relação risco/benefício das estatinas na prevenção primária de doença cardiovascular é geralmente favorável.

19 Jul, 2021 | 09:51h

Comunicado de imprensa: New study suggests benefit-to-harm balance of statins for healthy adults ‘generally favorable’ – BMJ

Estudo original: Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses – The BMJ

Comentário no Twitter

Statins are associated with a small increased risk of side effects in patients without a history of heart disease, but these effects are mild compared with the potential benefits of treatment in preventing major cardiovascular events, say researchers https://t.co/Yvn7Ojtx2F

— The BMJ (@bmj_latest) July 17, 2021

Revisão | Insuficiência adrenal induzida por glicocorticoide.

19 Jul, 2021 | 09:49h

Glucocorticoid induced adrenal insufficiency – The BMJ

Comentário no Twitter

◾ What factors affect the risk of Glucocorticoid induced adrenal insufficiency?
◾ What regimen can be used for glucocorticoid taper?
◾ How can adrenal function recovery be best assessed?

Read our latest clinical review to find out: https://t.co/m814c1rgIs

— The BMJ (@bmj_latest) July 13, 2021

Índice de massa corpórea e risco de diabetes em 57 países de baixa e média renda – “Limiares ótimos de IMC para rastreamento de diabetes variam de 23,8 kg/m2 entre homens no leste, sul e sudeste da Ásia até 28,8 kg/m2 entre mulheres do Oriente Médio, norte da África, América Latina e Caribe.

19 Jul, 2021 | 09:46h

Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults – The Lancet (link para o resumo – $ para o texto completo)

Relacionado: Study shows BMI cut-offs for obesity and diabetes risk do not work for non-white populations. E Study: Certain Racial/Ethnic Groups More Likely to Have Diabetes and Prediabetes at Lower Weights

Estudo de coorte | Aumento no risco de longo prazo para o desenvolvimento de anemia após cirurgia bariátrica – Em comparação com o grupo-controle, a incidência de anemia foi aumentada no grupo com by-pass gástrico (HR 5,05), no grupo com gastroplastia vertical (HR 2,67) e no grupo com banda gástrica (HR 2,76).

15 Jul, 2021 | 10:28h

Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study – The Lancet Diabetes & Endocrinology (link para o resumo – $ para o texto completo)

Resumo | Inibidores de SGLT2 e de agonistas receptores de GLP-1: Indicações novas e as já estabelecidas.

14 Jul, 2021 | 11:24h

SGLT2 Inhibitors and GLP-1 Receptor Agonists: Indications – American College of Cardiology

Revisão original: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications – The Lancet (link para o resumo – $ para o texto completo)

Diretriz relacionada: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes – This guidance recommends a risk-based approach, advising against starting SGLT-2 inhibitors or GLP-1 receptor agonists in patients with three or fewer cardiovascular risk factors and without established CVD or CKD.

Diretriz Científica AHA | Avaliação e direcionamento da saúde cardiovascular em pessoas transgênero e de gênero diverso.

12 Jul, 2021 | 11:27h

Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association – Circulation

Comunicado de imprensa: Discrimination, stress linked to poorer heart health in transgender, gender diverse adults – American Heart Association

Revisão | Lipoproteína (a) e doenças cardiovasculares.

12 Jul, 2021 | 11:21h

Lipoprotein(a) and Cardiovascular Diseases – JAMA (gratuito por tempo limitado)

Relatório preliminar do Consenso ADA | Tratamento do diabetes tipo 1 em adultos.

8 Jul, 2021 | 09:50h

The Management of Type 1 Diabetes in Adults — A Consensus Report by the ADA and EASD

Comentários: ADA/EASD Draft Guidance Aims to Bring Adults With Type 1 Diabetes Out of Shadows – Medscape (necessário cadastro gratuito) E New consensus report on adults with type 1 diabetes focuses on individualised care – Diabetes Times